Health & Science Technologies

Business

IDEX Beats Q4 Expectations on Surging Health & Science Demand, Charts Cautious 2026 Course

IDEX Corporation capped off fiscal 2025 with stronger-than-anticipated fourth-quarter results, propelled by a record-setting order surge in its Health & Science Technologies unit linked to data center and AI infrastructure. While management expressed confidence in its strategic evolution, it offered a measured outlook for the coming year amid a mixed industrial landscape.

Feb 5, 2026

Business

AT&T Doubles Down on Fiber and Healthcare, Betting on Connectivity Beyond Phones

AT&T's recent acquisition of Lumen's fiber assets and a new partnership in senior safety wearables signal a strategic pivot, aiming to transform its network into a platform for home broadband and connected health services.

Feb 4, 2026

Business

Healthpeak Navigates Life Science Headwinds with Strong Outpatient and Senior Housing Performance; Announces Senior Housing REIT Spin-Off

Healthpeak Properties reported resilient fourth-quarter results, driven by strength in its Outpatient Medical and Senior Housing segments, which helped counter a prolonged downturn in Life Science. The company announced a major portfolio repositioning, including a strategic lab acquisition and plans to spin off its Senior Housing portfolio into a new publicly traded REIT, Janus Living.

Feb 4, 2026

Business

RoundTable Healthcare Partners Acquires Colorescience, Bolstering Portfolio with Fast-Growing Skincare Brand

Private equity firm RoundTable Healthcare Partners has acquired the dermatologist-trusted skincare and sun protection brand Colorescience from 1315 Capital, as the company's annual sales approach the $100 million mark.

Feb 2, 2026

Business

SS&C Technologies Set to Report Q4 Earnings: Can the Financial Software Leader Maintain Its Beat Streak?

SS&C Technologies (SSNC) is poised to release its fourth-quarter earnings after the bell on Thursday. Investors will be watching to see if the company can extend its impressive track record of surpassing revenue estimates against a backdrop of slowing growth and sector-wide pressure.

Feb 4, 2026

Business

Hims & Hers Bets Big on Super Bowl Ad to Bridge Healthcare Gap and Investor Confidence

In a bold marketing move, telehealth company Hims & Hers is leveraging the Super Bowl's massive audience to spotlight healthcare inequality with its 'Rich People Live Longer' campaign. The push comes as the company expands into advanced diagnostics and treatments, while its stock navigates a significant valuation gap after recent volatility.

Feb 2, 2026

Business

Hims & Hers Health Stock Plunges 57%: Is the Telehealth Pioneer Now a Value Play?

Shares of the direct-to-consumer telehealth company Hims & Hers have been halved over the past six months, trading near $27. Investors are now weighing whether the steep sell-off presents a buying opportunity or signals deeper troubles ahead.

Feb 2, 2026

Business

Analysts Flag Potential Undervaluation in D&O Green Technologies, Shares Trade at 31% Discount

A recent discounted cash flow analysis suggests D&O Green Technologies Berhad's stock may be significantly undervalued, trading around RM0.60 against a calculated fair value of RM0.89. The semiconductor-focused firm's current valuation presents a notable gap for investors to consider.

Jan 31, 2026

Business

GE HealthCare Technologies Gains Analyst Favor, 2026 Outlook Brightens on Market Recovery

Goldman Sachs and Evercore ISI analysts have raised price targets for GE HealthCare Technologies (GEHC), citing a projected market recovery and strong capital expenditure trends by 2026. The medical devices firm is highlighted as a top hedge fund pick.

Jan 30, 2026

Business

P&G Bolsters Health Portfolio with Acquisition of Digestive Wellness Brand Wonderbelly

Consumer goods giant Procter & Gamble has agreed to acquire Wonderbelly, a fast-growing brand in the 'free-from' digestive health space, signaling a deeper push into the lucrative wellness category and a bid to attract younger, label-conscious consumers.

Jan 30, 2026

Business

IDEX Beats Q4 Estimates as Data Center Boom and Health Tech Fuel Growth

Industrial manufacturer IDEX surpassed Wall Street's revenue and profit forecasts for the fourth quarter, driven by robust demand in its Health, Science & Technology unit and key investments in data center infrastructure.

Feb 5, 2026

Business

AT&T Bets Big on Fiber and Connected Health: A Dual-Pronged Strategy for Growth

AT&T makes two significant strategic moves, acquiring Lumen's fiber assets to expand its broadband footprint and partnering to launch a network-based fall detection device for seniors, as it seeks to leverage its core infrastructure for future growth.

Feb 3, 2026

Business

Hims & Hers Health Bets on 'Labs' to Build a Personalized Healthcare 'Super App'

The telehealth company's new lab testing service is seen as a strategic move to evolve beyond online pharmacy, aiming to create a data-driven, end-to-end health platform. While shares have faced pressure, some analysts see long-term potential in its personalized care model.

Feb 5, 2026

Business

Johnson & Johnson Eyes Double-Digit Growth Horizon: Is the Healthcare Giant's Stock Now a Value Play?

After years of steady but modest expansion, Johnson & Johnson projects a significant acceleration in revenue, driven by a bold ambition to dominate the global oncology market. With shares trading at a premium, analysts debate if the stock's future growth potential justifies its current price.

Feb 4, 2026

Business

Siemens Healthineers Bets on Irish Innovation with New €10 Million R&D Hub

The medtech giant inaugurates a Centre of Excellence in Swords, aiming to accelerate development of its Atellica diagnostic systems and bolster Ireland's life sciences sector amid strategic corporate shifts.

Feb 2, 2026

Business

GE HealthCare Beats Q4 Estimates on Strong Product Launches and Recurring Service Growth

GE HealthCare Technologies posted better-than-expected fourth-quarter results, driven by robust demand in pharmaceutical diagnostics and momentum from new product rollouts. The company's focus on expanding its service-based revenue streams is central to its growth outlook.

Feb 5, 2026

Business

GE HealthCare Stock Slump: A Buying Opportunity or a Value Trap?

GE HealthCare Technologies' shares have faced recent pressure, lagging behind broader market and industry peers. A deep dive into valuation metrics, including discounted cash flow and P/E analysis, suggests the stock may be significantly undervalued. We examine the numbers and the narratives shaping investor sentiment.

Feb 5, 2026

Business

GE HealthCare Caps Strong 2025 with Record Backlog, Eyes Growth from New Product Pipeline

GE HealthCare Technologies reports robust Q4 2025 results, exceeding expectations with 4.8% organic revenue growth. The company enters 2026 with a record $21.8 billion backlog and a strategic focus on its innovation pipeline, including key launches in photon-counting CT and radiopharmaceuticals, while navigating tariff headwinds.

Feb 4, 2026

Business

GE HealthCare Tops Revenue Forecasts in Q4 2025, Driven by Imaging and Diagnostics Demand

GE HealthCare Technologies posted stronger-than-expected fourth-quarter revenue of $5.70 billion, a 7.1% year-over-year increase, while adjusted earnings per share of $1.44 also edged past analyst consensus. The performance highlights steady demand for its medical imaging and pharmaceutical diagnostics units amid ongoing healthcare capital investment.

Feb 4, 2026

Business

GE HealthCare Set to Report Q4 Earnings: Key Metrics and Market Sentiment in Focus

GE HealthCare Technologies prepares to release its fourth-quarter financial results amid steady analyst expectations and a mixed performance landscape for medical equipment peers.

Feb 3, 2026